Contact the Yasmin lawsuit attorneys of Williams Hart today - 800-761-3187.

Advisory panel sought for Yaz study

Posted on September 28th, 2011 No Comments

The FDA released a note warning of the increased risk of blood clot associated with new generation birth control, Yaz or Yasmin.

It did not say for sure that using the birth control will lead to this, but regulators stated that they are concerned of higher risks. Yasmin and Yaz are both very popular birth control pills and they both contain an ingredient, drospirenone, which may cause Deep-vein thrombosis.

This occurs when a blood clot happens in an extremity, such as the leg, and they become very dangerous if the clot moves to another vital organ. Symptoms include chest pain, leg pain and difficulty breathing. Preliminary results show that women who take drospirenone-containing birth control pills are 50 percent more likely to develop these blood clots than woman who took other contraceptives.

If you or a loved one has been taking either of these birth control pills and suffered a blood clot without being warning of the increased risk, contact the Yasmin blood clot lawyers of Williams Hart today by calling 800-761-3187.

Leave a Reply

Contact Williams Hart

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

Williams Hart Represents Yasmin/Yaz Victims Nationwide

Williams Hart represents clients across the country. Click here to learn more.

home  |  about us  |  attorneys  |  yaz  |  yasmin  |  ocella  |  faqs  |  articles  |  contact us  |  blog  |  Legal Colleagues  |  Log in
Copyright ©2007-2009 Williams Hart. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Hart's main office is located in Houston, Texas. Terms of Use. Disclaimer.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-761-3187

Search Engine Optimization provided by The Search Engine Guys.